Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT

Int J Pharm. 2012 Feb 28;423(2):509-15. doi: 10.1016/j.ijpharm.2011.11.045. Epub 2011 Dec 8.

Abstract

The synthesis of mesoporous silica nanoparticles (MSN) covalently encapsulating fluoresceine or a photosensitizer, functionalized with galactose on the surface is described. Confocal microscopy experiments demonstrated that the uptake of galactose-functionalized MSN by colorectal cancer cells was mediated by galactose receptors leading to the accumulation of the nanoparticles in the endosomal and lysosomal compartments. The MSN functionalized with a photosensitizer and galactose were loaded with the anti-cancer drug camptothecin. Those MSN combining drug delivery and photodynamic therapy were tested on three cancer cell lines and showed a dramatic enhancement of cancer cell death compared to separate treatments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Death / drug effects
  • Chemistry, Pharmaceutical
  • Drug Carriers*
  • Drug Compounding
  • Endosomes / metabolism
  • Fluorescein / chemistry
  • Fluorescein / metabolism
  • Galactose / chemistry
  • Galactose / metabolism*
  • HCT116 Cells
  • Humans
  • Lysosomes / metabolism
  • Microscopy, Confocal
  • Nanoparticles*
  • Nanotechnology
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Photochemotherapy*
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / metabolism
  • Photosensitizing Agents / pharmacology*
  • Porosity
  • Receptors, Cell Surface / metabolism
  • Silicon Dioxide / chemistry*
  • Technology, Pharmaceutical / methods
  • Time Factors

Substances

  • Drug Carriers
  • Photosensitizing Agents
  • Receptors, Cell Surface
  • galactose receptor
  • Silicon Dioxide
  • Fluorescein
  • Galactose